President Trump threatened 250% tariffs on pharma; Pfizer CEO contacted Trump about most favored nation pricing; Ex-X CEO joins eMed.

Despite not coming from a healthcare background, Yaccarino brings over a decade of experience in digital revenue and brand ...

Not all marking gauges are the same! Choosing the right one can make a huge difference in accuracy and ease. Here’s how to ...

Cat Asked ‘Do You Want To Come In?’ By Owner, Not Prepared For Her Reaction Palantir CEO warns of America’s AI ‘danger zone’ ...

Linda Yaccarino, the former CEO of Elon Musk 's social media platform X, has been appointed as the new CEO of eMed Population ...

Linda Yaccarino’s experience will be instrumental in developing innovative programs focusing on the future of peptide ...

Yaccarino, an advertising industry veteran, exited Elon Musk's X after two turbulent years during which she tried to revive ...

Linda Yaccarino, less than a month after stepping down as CEO of Elon Musk’s X, has found her next gig. Yaccarino has been ...

Linda Yaccarino, the former X CEO who left the social media company in the wake of yet another Elon Musk controversy, has ...

The post, at the company that focuses on care for GLP-1 users, comes after Yaccarino left Elon Musk's X in July.

Vertex Pharmaceuticals Inc. fell after an experimental pain drug failed to provide post-surgery benefits and US regulators ...

Former X CEO Linda Yaccarino said Tuesday she has taken on a new role leading a digital health platform, less than a month ...